| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| VIP |
vasoactive intestinal peptide |
6q24-q27 |
1(1/0/0)
|
IEA
|
| GNRH1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
8p21-p11.2 |
1(0/1/0)
|
IEA
|
| ANXA1 |
annexin A1 |
9q21.13 |
1(0/0/1)
|
TAS[16130169]
|
| ALOX12 |
arachidonate 12-lipoxygenase |
17p13.1 |
2(1/1/0)
|
IMP[15305153]; ISS
|
| EGR3 |
early growth response 3 |
8p23-p21 |
3(2/1/0)
|
IMP[18059339]
|
| MMP9 |
matrix metallopeptidase 9 |
20q13.12 |
1(1/0/0)
|
IMP[22984561]
|
| PPARD |
peroxisome proliferator-activated receptor delta |
6p21.2 |
1(1/0/0)
|
IEA
|
| CTSH |
cathepsin H |
15q25.1 |
1(0/0/1)
|
ISS
|
| PCNT |
pericentrin |
21q22.3 |
1(0/1/0)
|
IEA
|
| ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2q33.3-q34 |
2(1/1/0)
|
IMP[10722704]
|
| GCLC |
glutamate-cysteine ligase, catalytic subunit |
6p12 |
1(0/1/0)
|
IDA[10439045]
|
| EGR4 |
early growth response 4 |
2p13 |
1(0/1/0)
|
IBA
|
| KLHL20 |
kelch-like family member 20 |
1q25.1 |
1(0/1/0)
|
IMP[20389280]
|
| IGF1 |
insulin-like growth factor 1 (somatomedin C) |
12q23.2 |
1(1/0/0)
|
IMP[11949853]
|
| PALB2 |
partner and localizer of BRCA2 |
16p12.1 |
5(2/2/1)
|
IEA
|
| ATF5 |
activating transcription factor 5 |
19q13.33 |
1(0/1/0)
|
IEA
|
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
IDA[19203586]
|
| GLI3 |
GLI family zinc finger 3 |
7p13 |
1(1/0/0)
|
IEA
|
| IL6 |
interleukin 6 |
7p21-p15 |
1(0/1/0)
|
IDA[7595060]
|
| HSPA1A |
heat shock 70kDa protein 1A |
6p21.3 |
2(2/0/0)
|
IMP[17167422]; TAS[16130169]
|
| NGF |
nerve growth factor (beta polypeptide) |
1p13.1 |
2(1/1/0)
|
TAS
|
| ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
15q25.1 |
1(0/1/0)
|
IEA
|
| LIMS2 |
LIM and senescent cell antigen-like domains 2 |
2q21.1 |
1(1/0/0)
|
IEA
|
| EGFR |
epidermal growth factor receptor |
7p12 |
1(0/0/1)
|
IMP[18070883]
|
| PROK2 |
prokineticin 2 |
3p21.1 |
1(0/1/0)
|
IDA[12604792]
|
| GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
IDA[14744935]
|
| EGR2 |
early growth response 2 |
10q21.1 |
3(1/2/0)
|
IBA
|
| NR2E1 |
nuclear receptor subfamily 2, group E, member 1 |
6q21 |
1(1/0/0)
|
IEA
|
| XBP1 |
X-box binding protein 1 |
22q12.1 |
3(2/1/0)
|
ISS
|
| TFAP2B |
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
6p12 |
1(0/1/0)
|
IDA[17525748]; ISS
|
| PRKCZ |
protein kinase C, zeta |
1p36.33-p36.2 |
1(1/0/0)
|
IEA
|
| GDNF |
glial cell derived neurotrophic factor |
5p13.1-p12 |
1(1/0/0)
|
TAS[7830769]
|
| ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
20q11 |
1(0/0/1)
|
IEA
|
| IL10 |
interleukin 10 |
1q31-q32 |
1(0/1/0)
|
NAS[8312229]
|
| BCL2 |
B-cell CLL/lymphoma 2 |
18q21.3 |
2(0/2/0)
|
IDA[10506221]; IMP[17289999]
|
| SIRT1 |
sirtuin 1 |
10q21 |
1(0/1/0)
|
IMP[16892051]
|
| HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
12q24.2-q24.3 |
1(1/0/0)
|
IMP[10497210]; TAS[16130169]
|
| IL1RN |
interleukin 1 receptor antagonist |
2q14.2 |
2(2/0/0)
|
IEA
|
| NAA38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
17p13.1 |
1(1/0/0)
|
IMP[19398576]
|
| PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
IEA
|
| PSMB9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
6p21.3 |
1(1/0/0)
|
TAS
|
| PRLR |
prolactin receptor |
5p14-p13 |
1(1/0/0)
|
NAS[10585417]
|
| HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
9q33.3 |
1(0/1/0)
|
IMP[10760948]; TAS[16130169]
|
| EGR1 |
early growth response 1 |
5q23-q31 |
1(0/1/0)
|
IBA
|
| PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
1(1/0/0)
|
IMP[20348923]
|
| IL2RB |
interleukin 2 receptor, beta |
22q13 |
2(1/1/0)
|
IDA[7736574]
|
Basic Info
